Hysteroscopy pp 269-280 | Cite as

Hysteroscopy Classification for Endometrial Cancer



Endometrial cancer is the most commonly diagnosed gynecological cancer in Western countries. It usually presents with abnormal uterine bleeding, and current methods of dilation and curettage and office endometrial biopsy both present with a problem of upgraded pathological grade when compared with final hysterectomy results. Office hysteroscopic examination has a sensitivity of 78% for endometrial cancer. Evaluation of the background endometrium is necessary for comparison with the neoplastic lesion. Cerebroid pattern suggests at least a low-grade endometrial cancer. If glomerular pattern is present, high-grade endometrial cancer is highly suspected. Inspection begins with the endocervix, then a panoramic view of the endometrium. The neoplastic lesion should be compared with the background endometrium. Endocervix should be evaluated again to determine cervical involvement. A well-targeted biopsy can aid in a precise preoperative diagnosis.


Diagnostic hysteroscopy Endometrial cancer Glomerular pattern Cerebroid pattern 


  1. 1.
    Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63(1):11–30.CrossRefPubMedGoogle Scholar
  2. 2.
    Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, et al. Cancer statistics, 2004. CA Cancer J Clin. 2004;54(1):8–29.CrossRefPubMedGoogle Scholar
  3. 3.
    Van den Bosch T, Coosemans A, Morina M, Timmerman D, Amant F. Screening for uterine tumours. Best Pract Res Clin Obstet Gynaecol. 2012;26(2):257–66.CrossRefPubMedGoogle Scholar
  4. 4.
    Kitchener HC, Trimble EL. Endometrial Cancer Working Group of the Gynecologic Cancer I. Endometrial cancer state of the science meeting. Int J Gynecol Cancer. 2009;19(1):134–40.CrossRefPubMedGoogle Scholar
  5. 5.
    Dinkelspiel HE, Wright JD, Lewin SN, Herzog TJ. Contemporary clinical management of endometrial cancer. Obstet Gynecol Int. 2013;2013:583891.PubMedPubMedCentralGoogle Scholar
  6. 6.
    Bokhman JV. Two pathogenetic types of endometrial carcinoma. Gynecol Oncol. 1983;15(1):10–7.CrossRefPubMedGoogle Scholar
  7. 7.
    Lax SF, Kendall B, Tashiro H, Slebos RJ, Hedrick L. The frequency of p53, K-ras mutations, and microsatellite instability differs in uterine endometrioid and serous carcinoma: evidence of distinct molecular genetic pathways. Cancer. 2000;88(4):814–24.CrossRefPubMedGoogle Scholar
  8. 8.
    Bansal N, Yendluri V, Wenham RM. The molecular biology of endometrial cancers and the implications for pathogenesis, classification, and targeted therapies. Cancer Control. 2009;16(1):8–13.CrossRefPubMedGoogle Scholar
  9. 9.
    Mutter GL, Lin MC, Fitzgerald JT, Kum JB, Baak JP, Lees JA, et al. Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers. J Natl Cancer Inst. 2000;92(11):924–30.CrossRefPubMedGoogle Scholar
  10. 10.
    Hecht JL, Mutter GL. Molecular and pathologic aspects of endometrial carcinogenesis. J Clin Oncol. 2006;24(29):4783–91.CrossRefPubMedGoogle Scholar
  11. 11.
    Doll A, Abal M, Rigau M, Monge M, Gonzalez M, Demajo S, et al. Novel molecular profiles of endometrial cancer-new light through old windows. J Steroid Biochem Mol Biol. 2008;108(3–5):221–9.CrossRefPubMedGoogle Scholar
  12. 12.
    Sakuragi N, Nishiya M, Ikeda K, Ohkouch T, Furth EE, Hareyama H, et al. Decreased E-cadherin expression in endometrial carcinoma is associated with tumor dedifferentiation and deep myometrial invasion. Gynecol Oncol. 1994;53(2):183–9.CrossRefPubMedGoogle Scholar
  13. 13.
    Cancer Genome Atlas Research N, Kandoth C, Schultz N, Cherniack AD, Akbani R, Liu Y, et al. Integrated genomic characterization of endometrial carcinoma. Nature. 2013;497(7447):67–73.CrossRefGoogle Scholar
  14. 14.
    Towbin NA, Gviazda IM, March CM. Office hysteroscopy versus transvaginal ultrasonography in the evaluation of patients with excessive uterine bleeding. Am J Obstet Gynecol. 1996;174(6):1678–82.CrossRefPubMedGoogle Scholar
  15. 15.
    Emanuel MH, Verdel MJ, Wamsteker K, Lammes FB. A prospective comparison of transvaginal ultrasonography and diagnostic hysteroscopy in the evaluation of patients with abnormal uterine bleeding: clinical implications. Am J Obstet Gynecol. 1995;172(2 Pt 1):547–52.CrossRefPubMedGoogle Scholar
  16. 16.
    Koh WJ, Greer BE, Abu-Rustum NR, Apte SM, Campos SM, Chan J, et al. Uterine neoplasms, version 1.2014. J Natl Compr Cancer Netw. 2014;12(2):248–80.CrossRefGoogle Scholar
  17. 17.
    Singh S, Best C, Dunn S, Leyland N, Wolfman WL, Clinical Practice—Gynaecology C, et al. Abnormal uterine bleeding in pre-menopausal women. J Obstet Gynaecol Can. 2013;35(5):473–9.Google Scholar
  18. 18.
    Stovall TG, Photopulos GJ, Poston WM, Ling FW, Sandles LG. Pipelle endometrial sampling in patients with known endometrial carcinoma. Obstet Gynecol. 1991;77(6):954–6.PubMedGoogle Scholar
  19. 19.
    Shepherd JH. Revised FIGO staging for gynaecological cancer. Br J Obstet Gynaecol. 1989;96(8):889–92.CrossRefPubMedGoogle Scholar
  20. 20.
    Mariani A, Dowdy SC, Cliby WA, Gostout BS, Jones MB, TO W, et al. Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. Gynecol Oncol. 2008;109(1):11–8.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Leitao MM Jr, Kehoe S, Barakat RR, Alektiar K, Gattoc LP, Rabbitt C, et al. Comparison of D&C and office endometrial biopsy accuracy in patients with FIGO grade 1 endometrial adenocarcinoma. Gynecol Oncol. 2009;113(1):105–8.CrossRefPubMedGoogle Scholar
  22. 22.
    Larson DM, Johnson KK, Broste SK, Krawisz BR, Kresl JJ. Comparison of D&C and office endometrial biopsy in predicting final histopathologic grade in endometrial cancer. Obstet Gynecol. 1995;86(1):38–42.CrossRefPubMedGoogle Scholar
  23. 23.
    Frumovitz M, Singh DK, Meyer L, Smith DH, Wertheim I, Resnik E, et al. Predictors of final histology in patients with endometrial cancer. Gynecol Oncol. 2004;95(3):463–8.CrossRefPubMedGoogle Scholar
  24. 24.
    Eltabbakh GH, Shamonki J, Mount SL. Surgical stage, final grade, and survival of women with endometrial carcinoma whose preoperative endometrial biopsy shows well-differentiated tumors. Gynecol Oncol. 2005;99(2):309–12.CrossRefPubMedGoogle Scholar
  25. 25.
    Clark TJ, Voit D, Gupta JK, Hyde C, Song F, Khan KS. Accuracy of hysteroscopy in the diagnosis of endometrial cancer and hyperplasia: a systematic quantitative review. JAMA. 2002;288(13):1610–21.CrossRefPubMedGoogle Scholar
  26. 26.
    Gkrozou F, Dimakopoulos G, Vrekoussis T, Lavasidis L, Koutlas A, Navrozoglou I, et al. Hysteroscopy in women with abnormal uterine bleeding: a meta-analysis on four major endometrial pathologies. Arch Gynecol Obstet. 2015;291(6):1347–54.CrossRefPubMedGoogle Scholar
  27. 27.
    Deffieux X, Gauthier T, Menager N, Legendre G, Agostini A, Pierre F, et al. Hysteroscopy: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians. Eur J Obstet Gynecol Reprod Biol. 2014;178:114–22.CrossRefPubMedGoogle Scholar
  28. 28.
    Uno LH, Sugimoto O, Carvalho FM, Bagnoli VR, Fonseca AM, Pinotti JA. Morphologic hysteroscopic criteria suggestive of endometrial hyperplasia. Int J Gynaecol Obstet. 1995;49(1):35–40.CrossRefPubMedGoogle Scholar
  29. 29.
    Kurosawa H, Ito K, Nikura H, Takano T, Nagase S, Utsunomiya H, et al. Hysteroscopic inspection and total curettage are insufficient for discriminating endometrial cancer from atypical endometrial hyperplasia. Tohoku J Exp Med. 2012;228(4):365–70.CrossRefPubMedGoogle Scholar
  30. 30.
    Ianieri MM, Staniscia T, Pontrelli G, Di Spiezio SA, Manzi FS, Recchi M, et al. A new hysteroscopic risk scoring system for diagnosing endometrial hyperplasia and adenocarcinoma. J Minim Invasive Gynecol. 2016;23(5):712–8.CrossRefPubMedGoogle Scholar
  31. 31.
    Wilbur DC, Nayar R. Bethesda 2014: improving on a paradigm shift. Cytopathology. 2015;26(6):339–42.CrossRefPubMedGoogle Scholar
  32. 32.
    Su H, Pandey D, Liu LY, Yen CF, Wang CJ, Huang KG, et al. Pattern recognition to prognosticate endometrial cancer: the science behind the art of office hysteroscopy—a retrospective study. Int J Gynecol Cancer. 2016;26(4):705–10.CrossRefPubMedGoogle Scholar
  33. 33.
    Kasamatsu T, Onda T, Katsumata N, Sawada M, Yamada T, Tsunematsu R, et al. Prognostic significance of positive peritoneal cytology in endometrial carcinoma confined to the uterus. Br J Cancer. 2003;88(2):245–50.CrossRefPubMedGoogle Scholar
  34. 34.
    Tebeu PM, Popowski GY, Verkooijen HM, Casals J, Ludicke F, Zeciri G, et al. Impact of peritoneal cytology on survival of endometrial cancer patients treated with surgery and radiotherapy. Br J Cancer. 2003;89(11):2023–6.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Fadare O, Mariappan MR, Hileeto D, Wang S, McAlpine JN, Rimm DL. Upstaging based solely on positive peritoneal washing does not affect outcome in endometrial cancer. Mod Pathol. 2005;18(5):673–80.CrossRefPubMedGoogle Scholar
  36. 36.
    Zerbe MJ, Zhang J, Bristow RE, Grumbine FC, Abularach S, Montz FJ. Retrograde seeding of malignant cells during hysteroscopy in presumed early endometrial cancer. Gynecol Oncol. 2000;79(1):55–8.CrossRefPubMedGoogle Scholar
  37. 37.
    Obermair A, Geramou M, Gucer F, Denison U, Graf AH, Kapshammer E, et al. Does hysteroscopy facilitate tumor cell dissemination? Incidence of peritoneal cytology from patients with early stage endometrial carcinoma following dilatation and curettage (D&C) versus hysteroscopy and D&C. Cancer. 2000;88(1):139–43.CrossRefPubMedGoogle Scholar
  38. 38.
    Chang YN, Zhang Y, Wang YJ, Wang LP, Duan H. Effect of hysteroscopy on the peritoneal dissemination of endometrial cancer cells: a meta-analysis. Fertil Steril. 2011;96(4):957–61.CrossRefPubMedGoogle Scholar
  39. 39.
    Scrimin F, Wiesenfeld U, Galati EF, Monasta L, Ricci G. Hysteroscopic chasing for endometrial cancer in a low-risk population: risks of overinvestigation. Arch Gynecol Obstet. 2016;293(4):851–6.CrossRefPubMedGoogle Scholar
  40. 40.
    Kelekci S, Kaya E, Alan M, Alan Y, Bilge U, Mollamahmutoglu L. Comparison of transvaginal sonography, saline infusion sonography, and office hysteroscopy in reproductive-aged women with or without abnormal uterine bleeding. Fertil Steril. 2005;84(3):682–6.CrossRefPubMedGoogle Scholar
  41. 41.
    Tinelli R, Surico D, Leo L, Pinto V, Surico N, Fusco A, et al. Accuracy and efficacy of narrow-band imaging versus white light hysteroscopy for the diagnosis of endometrial cancer and hyperplasia: a multicenter controlled study. Menopause. 2011;18(9):1026–9.CrossRefPubMedGoogle Scholar
  42. 42.
    Surico D, Vigone A, Bonvini D, Tinelli R, Leo L, Surico N. Narrow-band imaging in diagnosis of endometrial cancer and hyperplasia: a new option? J Minim Invasive Gynecol. 2010;17(5):620–5.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  1. 1.Division of Gynecologic Endoscopy, Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital at Linkou Chang Gung University School of MedicineTao-YuanTaiwan

Personalised recommendations